Ricardo Araujo

Dr. Ricardo Araujo

INEB-Instituto Nacional de Engenharia Biomédica and i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016
Verified
Book Chapter
Closed access
Benedita Sampaio-MaiaBenedita Sampaio-Maia
Benedita Sampaio-Maia
Inês Morais CaldasInês Morais Caldas
Inês Morais Caldas
MPM L Pereira
M L Pereira
DPDaniel Pérez-Mongiovi
Daniel Pérez-Mongiovi
Ricardo AraujoRicardo Araujo
Ricardo Araujo

1 July 2020 in Soil Biology and Biochemistry
Verified
Journal Article
Closed access
Ricardo AraujoRicardo Araujo
Ricardo Araujo
VGVadakattu V.S.R. Gupta
Vadakattu V.S.R. Gupta
FRFrank Reith
Frank Reith
ABAndrew Bissett
Andrew Bissett
PMPauline Mele
Pauline Mele
Christopher FrancoChristopher Franco
Christopher Franco

1 September 2004 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
Ricardo AraujoRicardo Araujo
Ricardo Araujo
ARAcacio GonçaLves Rodrigues
Acacio GonçaLves Rodrigues
The objective of our study was to evaluate parameters influencing the germination of Aspergillus conidia. Inoculum concentration and age significantly influenced germination. Different incubation temperatures revealed significant differences among Aspergillus species. The internal human milieu provides the ideal conditions for the development of invasive disease by Aspergillus fumigatus but restricts invasion by Aspergillus flavus and Aspergillus niger .

1 January 2016
Verified
Book Chapter
Closed access
Benedita Sampaio-MaiaBenedita Sampaio-Maia
Benedita Sampaio-Maia
LSL Simões-Silva
L Simões-Silva
Manuel PestanaManuel Pestana
Manuel Pestana
Ricardo AraujoRicardo Araujo
Ricardo Araujo
ISIsabel João Soares Silva
Isabel João Soares Silva

1 April 2018 in Pharmacological Research
Verified
Journal Article
Open access
LSLiliana Simões-Silva
Liliana Simões-Silva
Ricardo AraujoRicardo Araujo
Ricardo Araujo
Manuel PestanaManuel Pestana
Manuel Pestana
ISIsabel João Soares Silva
Isabel João Soares Silva
Benedita Sampaio-MaiaBenedita Sampaio-Maia
Benedita Sampaio-Maia
Chronic kidney disease (CKD) is associated with an imbalanced human microbiome due not only to CKD-associated factors such as uremia, increased inflammation and immunosuppression, but also to pharmacological therapies and dietary restrictions. End-stage renal disease patients require renal replacement therapies commonly in the form of hemodialysis (HD) or peritoneal dialysis (PD). HD implies the existence of a vascular access, such as an arteriovenous fistula/graft or a venous catheter, whereas PD implies a long-term peritoneal catheter and the constant inflow of peritoneal dialysate. Also, dietary adaptations are mandatory in both therapies. This revision explores the impact of HD or PD therapies on human microbiome. HD and PD appear to be associated with different changes in the gut microbiome, for example a decrease in Proteobacteria relative abundance in HD patients and increase in PD patients. Both therapies may also have an impact on the human microbiome beyond the gut, leading to increased relative abundance of specific bacteria in the blood microbiome of HD patients and increased relative abundance of other bacteria in the peritoneal microbiome of PD patients. HD and PD catheter biofilms may also play an important role in the changes observed in these microbiomes. A more interdisciplinary approach is needed to further clarify the role of microbial groups other than bacteria in all body habitats to allow the complete understanding of the impact of HD or PD on the microbiome of CKD patients. Moreover, strategies that promote a healthy balance of the human microbiome on these patients should be explored.

15 June 2014 in Medical Mycology
Verified
Journal Article
Closed access
FMF. Monteiro-Da-Silva
F. Monteiro-Da-Silva
Ricardo AraujoRicardo Araujo
Ricardo Araujo
Benedita Sampaio-MaiaBenedita Sampaio-Maia
Benedita Sampaio-Maia
Oral microbiota is one of the most complex and diverse microbial communities in the human body. In the present study, we aimed to characterize oral fungi biodiversity and stability over time in a group of healthy participants with good oral health. Oral health and oral fungal microbiota were evaluated in 40 healthy individuals. A follow-up of 10 participants was carried out 28 weeks and 30 weeks after the first sampling. Oral rinse was collected and incubated in a fungal selective medium at 25ºC and 37ºC for 7 days. Fungi were identified based on macro- and microscopic morphology. API/ID32C was used for yeast identification, and molecular techniques were used to identify the most prevalent nonidentified moulds, mainly by sequencing 18S and internally transcribed spacer regions. Moulds were recovered from all participants and yeast from 92.5%. The most frequently isolated fungi were Candida spp., Rhodotorula spp., Penicillium spp., Aspergillus spp., and Cladosporium spp. The oral fungal community presented a high interindividual variability, but the frequency and quantification of each fungal taxon was constant over the 30-week observation period, showing a consistent intraindividual stability over time. The intraindividual stability opposed to interindividual variability may suggest a common and a variable group of fungi in the oral cavity.